Latest KFF Health News Stories
His Anesthesia Provider Billed Medicare Late. He Got Sent to Collections for the $3,000 Tab.
Medicare was supposed to cover the entire cost of his procedure. But after the anesthesia provider failed to file its claims in a timely manner, it billed the patient instead.
New Weight Loss Drugs Carry High Price Tags and Lots of Questions for Seniors
Although nearly 40% of Americans 60 and older are obese, Medicare doesn’t cover weight loss medications. Meanwhile, studies haven’t thoroughly examined new drugs’ impact on older adults.
¿Cuánto costará la píldora anticonceptiva de venta libre? ¿La cubrirán los seguros?
Los defensores de la salud reproductiva celebraron esta histórica aprobación como un paso que puede ayudar a millones de personas a evitar embarazos no deseados, que ocurren casi la mitad de las veces en los Estados Unidos.
Once the New Over-the-Counter Birth Control Pill Is Available, What About Cost and Coverage?
The Food and Drug Administration’s approval is viewed as groundbreaking, but many details still must be figured out.
With More People Giving Birth at Home, Montana Passed a Pair of Laws to Make It Easier
The state now requires Medicaid to cover midwife services and has expanded the list of prescription drugs midwives can administer.
An Arm and a Leg: A $229,000 Medical Bill Goes to Court
Lisa French was told her surgery would cost $1,337. But the hospital sent her a bill for $229,000, then sued her. The case went all the way to the Colorado Supreme Court. The court’s ruling could have major implications for determining a “reasonable price” in health care.
Decisión de Eli Lilly de bajar el precio de su insulina logrará cambios históricos en los costos
Expertos en precios de medicamentos celebraron la noticia de Eli Lilly y otros esfuerzos. Y estas otras iniciativas para llevar al mercado insulina de menor costo, a su vez, presionarían a Eli Lilly para que mantuviera sus precios bajos.
Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom.
Eli Lilly’s news that it plans to cut insulin costs for patients will help, not hinder, the recent efforts in California and by entrepreneurs such as Mark Cuban to offer lower-cost alternatives, drug pricing experts said.
After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens
Colorado’s proposed legislation to cap the copay for the EpiPen is part of a nationwide trend as more states try to shield patients from skyrocketing drug prices.
Se acaba la era de las vacunas y las pruebas gratuitas contra covid. ¿Quién va a pagar?
Las personas podrán obtener estas vacunas a bajo costo o sin costo mientras duren los suministros del gobierno. Luego, dependerá de su seguro de salud.
Era of ‘Free’ Covid Vaccines, Test Kits, and Treatments Is Ending. Who Will Pay the Tab Now?
Insurers, employers, and taxpayers will all be affected as drug manufacturers move these products to the commercial market.
Readers and Tweeters Diagnose Greed and Chronic Pain Within US Health Care System
KHN gives readers a chance to comment on a recent batch of stories.
Nueva herramienta ayudaría a comparar costos de hasta 500 servicios médicos
Desde el 1 de enero, las aseguradoras y los empleadores que ofrecen planes de salud deben proporcionar calculadoras en línea para que los pacientes obtengan estimaciones detalladas de lo que deberán por una variedad de servicios y medicamentos, teniendo en cuenta sus deducibles y copagos.
Want a Clue on Health Care Costs in Advance? New Tools Take a Crack at It
Another effort to make upfront cost comparisons possible in an industry known for its opaqueness: an online tool for consumers to get some idea of what they may pay for medical care.
What Germany’s Coal Miners Can Teach America About Medical Debt
Coal mining ended in Germany’s Saarland a decade ago, but the transition away from coal has been smoother than in West Virginia, which has more medical debt than any state in America.
Employers Use Patient Assistance Programs to Offset Their Own Costs
Some insurers and employers are tapping into assistance programs meant for individual patients. The concern: Some costly drugs could be harder for patients to access.
Medicare Plan Finder Likely Won’t Note New $35 Cap on Out-of-Pocket Insulin Costs
In August, Congress approved a $35 cap on what seniors will pay for insulin, but that change came too late to add to the online tool that helps Medicare beneficiaries compare dozens of drug and medical plans. Federal officials say beneficiaries who use insulin will have the opportunity to switch plans after open enrollment ends Dec. 7.
Cash for Colonoscopies: Colorado Tries to Lower Health Costs Through Incentives
State employees could receive checks ranging from $50 to thousands of dollars if they choose the right provider.
Private Equity Sees the Billions in Eye Care as Firms Target High-Profit Procedures
As private equity groups are swarming into aging America’s eye care, the consolidation is costing the U.S. health care system and patients more money.
‘An Arm and a Leg’: The New Cap on Medicare Drug Costs
In this episode, Julie Rovner, chief Washington correspondent for KHN, guides listeners through decades of dealings between Congress and Big Pharma.
